<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-147 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-147</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-147</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-7.html">extraction-schema-7</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <p><strong>Paper ID:</strong> paper-30fd5864630c1ad66ac7202066209b67717c09cd</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/30fd5864630c1ad66ac7202066209b67717c09cd" target="_blank">The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors</a></p>
                <p><strong>Paper Venue:</strong> Frontiers in Molecular Biosciences</p>
                <p><strong>Paper TL;DR:</strong> This work provides a comprehensive overview of the current understanding of exosomes-mediated reprogramming of cells in PMN formation and highlights the importance of knowing the carrier and removal status of canine coronavirus.</p>
                <p><strong>Paper Abstract:</strong> Exosomes or other extracellular vesicles released from cells play an important role in cell-to-cell communication by transferring bio-information (DNA, coding/non-coding RNA, and proteins), which indicates parental cell status to recipient cells in the extracellular environment. Increasingly, evidence shows that tumor-derived exosomes mediate tumor pre-metastatic niche (PMN) remodeling to establish a supportive and receptive niche to promote tumor cell colonization and metastasis. Uptake of genetic information by target cells in the extracellular environment triggers epigenetic changes that contribute to PMN formation. Here, we provide a comprehensive overview of the current understanding of exosomes-mediated reprogramming of cells in PMN formation.</p>
                <p><strong>Cost:</strong> 0.023</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e147.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e147.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Breast->Lung (integrin/miR-105/miR-122)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Breast cancer metastasis to lung (exosome-mediated integrin and miRNA mechanisms)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Breast cancer-derived exosomes carry specific integrins and miRNAs that direct organotropic delivery to lung endothelium and remodel the lung pre-metastatic niche by increasing vascular permeability and reprogramming metabolism to favor tumor colonization.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Tumour Exosome Integrins Determine Organotropic Metastasis.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>Breast cancer</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>Lung</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Pre-metastatic niche formation via exosome organotropism (seed-and-soil): exosomal integrins target and adhere to resident lung cells; exosomal miR-105 destroys endothelial tight junctions increasing vascular permeability; exosomal miR-122 reprograms niche cell metabolism to increase nutrient availability for cancer cells.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Exosomal integrins (α6β4, α6β1) associated with lung tropism; exosomal miR-105 (targets ZO-1), exosomal miR-122 (targets PKM2 and GLUT1), and in other studies exosomal integrin β4 interaction with surfactant protein C mediates uptake.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Lung endothelial tight junction proteins (ZO-1) and surfactant protein C on lung cells as docking/uptake partners; altered endothelial permeability and metabolic state of lung stromal cells (reduced PKM2/GLUT1 expression).</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Hoshino et al. performed exosomal proteomics across tumor types and correlated exosomal integrin expression patterns (α6β4/α6β1) with lung metastasis in animal models and clinical data; Zhou et al. (2014) showed breast cancer exosomal miR-105 downregulates ZO-1 in microvascular endothelial cells, increasing vascular permeability and promoting metastasis; Fong et al. (2015) demonstrated breast cancer exosomal miR-122 uptake by lung fibroblasts and astrocytes reduces PKM2/GLUT1 and glucose uptake, increasing glucose availability for tumor cells and promoting metastasis in vivo.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Exosomal integrin profiles could predict lung metastasis; blocking exosome release/uptake or targeting exosomal miR-105/miR-122 are proposed strategies; organotropic exosomes could be harnessed as delivery vehicles (paper cites use of exosomes to deliver therapeutics to lung).</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Vascular remodeling/ permeability, metabolic reprogramming of niche cells, and PMN inflammation/immunomodulation are additional contributing factors.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors', 'publication_date_yy_mm': '2021-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e147.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e147.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Breast/Lung->Brain (CEMIP)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Breast and lung cancer metastasis to brain mediated by exosomal CEMIP</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Breast- and lung-derived tumor exosomes enriched for CEMIP protein induce a pro-inflammatory vascular niche in brain (and promote vascular remodeling), facilitating brain colonization by tumor cells and associating with clinical brain metastasis progression.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Tumour Exosomal CEMIP Protein Promotes Cancer Cell Colonization in Brain Metastasis.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>Breast cancer and lung cancer</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>Brain</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Exosomal delivery of CEMIP to brain endothelial cells and microglia upregulates pro-inflammatory cytokines (Ptgs2, Tnf, Ccl/Cxcl), creating a pro-inflammatory vascular niche and promoting vascular remodeling/angiogenesis that supports metastatic colonization.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Exosomal CEMIP (cell migration-inducing and hyaluronan-binding protein) present in tumor-derived exosomes.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Brain endothelial cells and microglia respond by upregulating inflammatory cytokines and remodeling vasculature; increased vascular permeability/angiogenesis in brain microenvironment.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Rodrigues et al. (2019) showed brain-tropic breast cancer exosomes carrying CEMIP are taken up by brain endothelial and microglial cells, induce Ptgs2/Tnf/Ccl/Cxcl expression and vascular remodeling; clinical correlation reported that exosomal CEMIP levels predict brain metastasis progression and patient survival.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Exosomal CEMIP could serve as a predictive biomarker for brain metastasis and a potential target to prevent brain PMN formation.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Inflammation-driven PMN formation and angiogenesis; immune cell recruitment are implicated.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors', 'publication_date_yy_mm': '2021-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e147.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e147.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Gastric->Liver (EGFR exosomes)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Gastric cancer metastasis to liver via exosome-delivered EGFR</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Gastric tumor-derived exosomes transfer EGFR to liver stromal cells, which alters the hepatic microenvironment to favor colonization by gastric cancer cells through activation of HGF/c-MET signaling.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Exosome-delivered EGFR Regulates Liver Microenvironment to Promote Gastric Cancer Liver Metastasis.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>Gastric cancer</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>Liver</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Exosome-mediated horizontal transfer of EGFR to resident liver stromal cells activates hepatocyte growth factor (HGF) signaling and creates a fertile microenvironment (PMN) that attracts c-MET-expressing migrated cancer cells.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Exosomal epidermal growth factor receptor (EGFR) present in gastric cancer-derived exosomes.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Liver stromal cells integrate exosomal EGFR and respond by activating HGF, which acts on c-MET on incoming cancer cells to support engraftment and growth.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Zhang et al. (2017) reported that gastric cancer exosomes containing EGFR are delivered to the liver, integrate with liver stromal cells, activate HGF signaling, and thereby promote liver-specific metastasis in experimental models.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Targeting exosomal EGFR transfer or HGF/c-MET signaling in the liver microenvironment could attenuate gastric cancer liver metastasis; exosomal EGFR might be a biomarker of liver tropism.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>PMN formation through stromal activation and growth-factor-mediated attraction of migrated tumor cells.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors', 'publication_date_yy_mm': '2021-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e147.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e147.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PDAC->Liver (MIF)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Pancreatic ductal adenocarcinoma (PDAC) metastasis to liver via exosomal MIF</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>PDAC-derived exosomes carrying macrophage migration inhibitory factor (MIF) are taken up by hepatic Kupffer cells, triggering a cascade (TGF-β secretion, hepatic stellate cell activation, BMDC recruitment) that establishes a pro-metastatic liver niche.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Pancreatic Cancer Exosomes Initiate Pre-metastatic Niche Formation in the Liver.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>Pancreatic ductal adenocarcinoma (PDAC)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>Liver</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Exosomal MIF from primary PDAC targets Kupffer cells in liver, inducing TGF-β production, which activates hepatic stellate cells (HSCs); activated HSCs remodel the liver PMN and recruit bone marrow-derived cells (macrophages/granulocytes) to support metastatic seeding.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Exosomal macrophage migration inhibitory factor (MIF).</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Kupffer cells (resident liver macrophages) uptake exosomal MIF and change secretory phenotype (TGF-β); activation of HSCs and recruitment of BMDCs produces an inflammatory, fibrotic, and permissive PMN.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Costa-Silva et al. (2015) demonstrated uptake of PDAC exosomal MIF by Kupffer cells in mice, subsequent TGF-β induction, HSC activation, BMDC recruitment, and enhanced liver metastasis in vivo; blockade of exosomal MIF reduced PMN formation and metastasis.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Targeting exosomal MIF or interrupting Kupffer cell/HSC activation could prevent liver PMN formation and PDAC liver metastasis; exosomal MIF may serve as a biomarker for metastatic risk.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Inflammation, recruitment of bone marrow-derived cells, and extracellular matrix remodeling are contributing factors.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors', 'publication_date_yy_mm': '2021-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e147.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e147.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>CCRCC->Lung (CD103+ CSC exosomes)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Clear cell renal cell carcinoma (CCRCC) metastasis to lung mediated by CD103+ cancer stem cell exosomes</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Exosomes released from CD103+ cancer stem cells in CCRCC selectively target the lung and promote lung metastasis through delivery of oncogenic miRNA cargo that induces EMT and pro-metastatic changes in the lung niche.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>CD103-positive CSC Exosome Promotes EMT of clear Cell Renal Cell Carcinoma: Role of Remote MiR-19b-3p</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>Clear cell renal cell carcinoma (CCRCC)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>Lung</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Organotropism via cancer stem cell-derived exosomes (CD103+); exosomes deliver microRNA cargo to lung cells to promote epithelial-to-mesenchymal transition (EMT) and prepare a permissive PMN.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>CD103+ cancer stem cell-derived exosomes containing oncogenic microRNAs (table lists miR-15b-3p; referenced study title indicates miR-19b-3p).</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Lung resident cells uptake CSC exosomes and undergo molecular changes (EMT-related signaling) that facilitate tumor cell colonization.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Wang et al. (2019) reported that CD103+ CSC exosomes from CCRCC specifically target lung, promote EMT, and are associated with lung metastasis in experimental models (in vivo xenografts and mechanistic assays for miRNA cargo effects).</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Targeting CSC exosome production, CD103-mediated targeting, or the specific miRNA cargo could reduce lung metastatic seeding; exosomal signatures might predict lung tropism.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>EMT induction, exosome-mediated horizontal transfer of miRNAs, and PMN remodeling.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors', 'publication_date_yy_mm': '2021-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e147.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e147.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>CRC->Liver/Lung (miR-25-3p; miR-21; miR-934)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Colorectal cancer metastasis to liver and lung via multiple exosome-mediated mechanisms</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Colorectal cancer (CRC)-derived exosomes carry different miRNAs and transcriptional regulators that induce vascular permeability/angiogenesis and immunomodulation in liver and lung PMNs, promoting organ-specific metastasis.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Cancer-derived Exosomal miR-25-3p Promotes Pre-metastatic Niche Formation by Inducing Vascular Permeability and Angiogenesis.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>Colorectal cancer (CRC)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>Liver and lung (also sentinel lymph node / lymphatic network)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Multiple exosome-mediated mechanisms: (1) vascular remodeling—exosomal miR-25-3p silences KLF2/KLF4 in endothelial cells increasing VEGFR2 and decreasing tight junction proteins to induce angiogenesis and vascular leakiness in liver/lung PMN; (2) immune/inflammatory niche—exosomal miR-21 binds TLR7 in liver macrophages to induce IL-6-secreting proinflammatory phenotype facilitating liver metastasis; (3) immunosuppression—exosomal miR-934 induces M2 macrophage polarization via PTEN downregulation/PI3K-AKT, promoting liver metastasis; (4) lymphatic remodeling—exosomal IRF-2 boosts VEGF-C secretion from macrophages, promoting sentinel lymph node lymphangiogenesis.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Exosomal miR-25-3p, miR-21, miR-934, and exosomal IRF-2 (transcription factor) and other exosomal contents that modulate endothelial and immune cells.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Endothelial cells (VEGFR2 expression, decreased ZO-1/occludin/Claudin5), liver macrophages/Kupffer cells (TLR7-mediated IL-6 secretion, M2 polarization), macrophage-driven VEGF-C secretion for lymphangiogenesis.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Zeng et al. (2018) showed CRC exosomal miR-25-3p is transferred to endothelial cells, suppresses KLF2/KLF4, upregulates VEGFR2 and downregulates tight-junction proteins, promoting vascular permeability and metastasis to liver/lung in vivo; Shao et al. (2018) demonstrated exosomal miR-21 binding to TLR7 mediates liver macrophage polarization to an IL-6-secreting phenotype; Zhao et al. (2020) showed exosomal miR-934 induces M2 polarization via PTEN/PI3K/AKT and establishes a CXCL13/CXCR5/NFκB/miR-934 feedback loop promoting liver metastasis; Sun et al. (2019) reported exosomal IRF-2 from CRC boosts VEGF-C secretion from macrophages and remodels sentinel lymph node lymphatics.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td>Jiang et al. (2021) reported CRC-derived exosomal ANGPTL1 attenuates CRC liver metastasis by altering Kupffer cell secretion patterns and inhibiting MMP9-induced vascular leakiness, which conflicts with other reports that CRC exosomes promote liver vascular leakiness.</td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Targeting specific exosomal miRNAs (miR-25-3p, miR-21, miR-934) or modulating Kupffer/macrophage responses may prevent CRC liver/lung metastasis; exosomal ANGPTL1 might be therapeutically protective and could be exploited.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Vascular permeability/angiogenesis, immune cell polarization (M1 vs M2), lymphangiogenesis, and PMN metabolic/ECM remodeling.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors', 'publication_date_yy_mm': '2021-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e147.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e147.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Melanoma->Lung/Brain (inflammation/immune effects)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Melanoma metastasis to lung and brain via exosome-induced proinflammatory signaling and lymphatic escape</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Melanoma-derived exosomes can provoke proinflammatory signaling in lung fibroblasts and brain astrocytes and disrupt subcapsular sinus macrophage barriers in lymph nodes, promoting dissemination to lung, brain, and via lymphatics.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Melanoma-derived Extracellular Vesicles Instigate Proinflammatory Signaling in the Metastatic Microenvironment.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>Melanoma</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>Lung and brain (and lymphatic dissemination)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Exosome-triggered proinflammatory signaling in resident stromal cells (lung fibroblasts, brain astrocytes) recruits immune cells and upregulates inflammation-activating factors (Hmgb1, Tslp, Irf1), creating a PMN; melanoma exosomes can also disrupt CD169+ macrophage barrier in lymph node subcapsular sinus facilitating lymphatic dissemination.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Melanoma-derived extracellular vesicles/exosomes (cargo not specified as single factor in summary).</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Lung fibroblasts and brain astrocytes upregulate Hmgb1, Tslp, Irf1 and recruit immune cells; subcapsular sinus CD169+ macrophage layer integrity is compromised to allow lymphatic escape.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Gener Lahav et al. (2019) showed metastatic melanoma exosomes induce inflammatory signaling in lung fibroblasts and brain astrocytes promoting immune cell recruitment and PMN formation; Pucci et al. (2016) reported melanoma exosomes can break through the CD169+ macrophage layer in the lymph node subcapsular sinus and enable dissemination via lymphatics.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Modulating exosome-induced inflammatory signaling in target organs or preserving lymph node macrophage barriers could suppress melanoma dissemination.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Inflammation-driven PMN formation, immune cell recruitment, and lymphatic remodeling.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors', 'publication_date_yy_mm': '2021-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Tumour Exosome Integrins Determine Organotropic Metastasis. <em>(Rating: 2)</em></li>
                <li>Pancreatic Cancer Exosomes Initiate Pre-metastatic Niche Formation in the Liver. <em>(Rating: 2)</em></li>
                <li>Exosome-delivered EGFR Regulates Liver Microenvironment to Promote Gastric Cancer Liver Metastasis. <em>(Rating: 2)</em></li>
                <li>Cancer-derived Exosomal miR-25-3p Promotes Pre-metastatic Niche Formation by Inducing Vascular Permeability and Angiogenesis. <em>(Rating: 2)</em></li>
                <li>Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. <em>(Rating: 2)</em></li>
                <li>Cancer-secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis. <em>(Rating: 2)</em></li>
                <li>Tumour Exosomal CEMIP Protein Promotes Cancer Cell Colonization in Brain Metastasis. <em>(Rating: 2)</em></li>
                <li>Colorectal Cancer Exosomes Induce Lymphatic Network Remodeling in Lymph Nodes. <em>(Rating: 2)</em></li>
                <li>CD103-positive CSC Exosome Promotes EMT of clear Cell Renal Cell Carcinoma: Role of Remote MiR-19b-3p <em>(Rating: 1)</em></li>
                <li>Tumour-derived Extracellular Vesicles Instigate Proinflammatory Signaling in the Metastatic Microenvironment. <em>(Rating: 1)</em></li>
                <li>Tumour Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils. <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>